Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.985 EUR | 0.00% | -2.48% | -4.37% |
06-23 | Hamilton Thorne Maintained at Buy at Stifel GMP on No Impact From U.S. IVF Actions; Price Target Kept at C$2.55 | MT |
05-14 | Hamilton Thorne Q1 Loss Widens Even as Sales Increase | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company sustains low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 86.38 times its estimated earnings per share for the ongoing year.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.37% | 162M | - | ||
+4.18% | 211B | B | ||
+8.00% | 185B | B- | ||
+31.86% | 158B | B- | ||
+33.21% | 113B | A- | ||
+2.28% | 64.32B | A- | ||
+21.14% | 55.66B | B+ | ||
+0.11% | 48.41B | B+ | ||
-6.76% | 37.82B | A | ||
+0.78% | 35.57B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HTL Stock
- 0ZM Stock
- Ratings Hamilton Thorne Ltd.